Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).
Jongen PJ, Hengstman G, Hupperts R, Schrijver H, Gilhuis J, Vliegen JH, Hoogervorst E, van Huizen M, van Munster E, Samijn J, de Schryver E, Siepman T, Tonk M, Zandbergen E, ten Holter J, van der Kruijk R, Borm G. Jongen PJ, et al. Among authors: borm g. BMC Neurol. 2011 Mar 30;11:40. doi: 10.1186/1471-2377-11-40. BMC Neurol. 2011. PMID: 21450086 Free PMC article. Clinical Trial.
Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.
Jongen PJ, Sindic C, Carton H, Zwanikken C, Lemmens W, Borm G; Functional composite and quality of Life in Avonex-treated Relapsing multiple sclerosis patients study group. Jongen PJ, et al. Among authors: borm g. J Neurol. 2010 Apr;257(4):584-9. doi: 10.1007/s00415-009-5378-x. Epub 2009 Nov 18. J Neurol. 2010. PMID: 19921303 Clinical Trial.
Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients.
van Nimwegen M, Speelman AD, Smulders K, Overeem S, Borm GF, Backx FJ, Bloem BR, Munneke M; ParkFit Study Group. van Nimwegen M, et al. Among authors: borm gf. BMC Neurol. 2010 Aug 19;10:70. doi: 10.1186/1471-2377-10-70. BMC Neurol. 2010. PMID: 20723221 Free PMC article. Clinical Trial.
Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice.
Jongen PJ, Sindic C, Sanders E, Hawkins S, Linssen W, van Munster E, Frequin S, Borm G; Functional Composite and Quality of Life in Avonex-treated Relapsing Multiple Sclerosis Patients Study Group. Jongen PJ, et al. Among authors: borm g. PLoS One. 2011;6(10):e26568. doi: 10.1371/journal.pone.0026568. Epub 2011 Oct 25. PLoS One. 2011. PMID: 22046309 Free PMC article. Clinical Trial.
Development and external validation of a new PTA assessment scale.
Jacobs B, van Ekert J, Vernooy LP, Dieperink P, Andriessen TM, Hendriks MP, van Vugt AB, Emons MA, Borm GF, Vos PE. Jacobs B, et al. BMC Neurol. 2012 Aug 8;12:69. doi: 10.1186/1471-2377-12-69. BMC Neurol. 2012. PMID: 22873279 Free PMC article.
Physical inactivity in Parkinson's disease.
van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, Overeem S, Deeg DJ, Borm GF, van der Horst MH, Bloem BR, Munneke M. van Nimwegen M, et al. J Neurol. 2011 Dec;258(12):2214-21. doi: 10.1007/s00415-011-6097-7. Epub 2011 May 26. J Neurol. 2011. PMID: 21614433 Free PMC article.
181 results